Green Talk®

Whole Body, Healthy Home, and Sustainable Garden Inspiration

 Get Inspired.  Sign Up for Our Free Newsletter

  • About
    • Press
    • Terms of Use
    • Privacy Policy
  • New Here?
  • Advertise
  • Contact
  • Hire Me
  • 5 Reasons to Subscribe!
  • Build Green
  • Gardening
  • Green Business
  • Green Living
  • Green Home
  • Recycling
  • Tech

FDA Approves Latisse, Eyelash Enhancer, Yet No Ban on BPA.

January 3, 2009 By: Anna8 Comments

eye

Photo by permission of Chloe Delong

The Food and Drug Administration (FDA) recently approved Latisse, which is made by Allergan to treat a condition known as hypotrichosis of the eyelashes, or in plain English, a person who does not have enough or inadequate eyelashes. According to Allergan, lush eyelashes were realized within sixteen weeks of initial treatment. Allergan is also the maker of Botox.

“LATISSE(TM) fulfills a significant and previously unmet need in the medical aesthetic marketplace with a product approved by the FDA that increases the growth of eyelashes, making them longer, thicker and darker,” said Scott Whitcup, M.D., Allergan’s Executive Vice President of Research and Development. “As the global leader in medical aesthetics, LATISSE(TM) exemplifies our continuing commitment to developing innovative treatments that are studied in well-controlled clinical trials, manufactured to pharmaceutical standards, appropriately labeled for use, and available to consumers as a prescription product,” as stated in the Company’s press release.

The active ingredient in Latisse is bimatroprost, which is responsible for the new growth of eye lashes.  It is the same ingredient in one of Allergan’s other drugs, Lumigan, which is used to treat glaucoma.  Doctors found that Lumigan caused their patients’ eyelashes to become lush.  In clinical trials, Allergan confirmed this finding and created Latisse, which according to the Company has mild side effects.

The treatment is only for upper eyelid margins at the base of the eyelashes.  The drug literature states  that known side effects are eye redness, dryness of the eyes, eye irritation, and temporary darkening of the skin of the eyelid. However, it further notes that temporary darkening of the skin may be reversible. In addition, the Company notes that the drug may also permanently darken the iris of the eye as well as promote hair growth in other skin areas that the treatment applicator may touch. Therefore, it is imperative that excess residue be blotted away.

“It is also possible for a difference in eyelash length, thickness, fullness, pigmentation, number of eyelash hairs, and/or direction of eyelash growth to occur between eyes. These differences, should they occur, will usually go away if you stop using LATISSE(TM),” as further stated in the drug literature.

Well, that is comforting. So either you could look like a model or a freak.

However, use of this drug is not a cure all.  Once the drug is discontinued, the lashes will revert back to their original length.  This product has not been tested for pediatric use although the FDA has encouraged the Company to further study Latisse’s effects on children to help those children who have lost their eye lashes due to chemotherapy.

Cost for a thirty day treatment is $120.00. The cost does not apparently scare some. The Boston Herald polled their readers to see if they would consider using Latisse.  The poll revealed that 38% of their readers would use the product, 56% would not and 6% were undecided. Moreover, according to Reuters, Allergan is predicting $500 million in annual global sales.

Given our obsession with vanity, Allergan will be batting its eye lashes right to the bank since Latisse will be another Botox drug for the cosmetic industry. Who knows what the future will bring.  Since Latisse can promote unwanted hair growth, is Latisse a stepping stone to a drug that can cures baldness? Speculators, you might want to buy Allergan’s stock now.

Not to down play what this drug could mean for people who have lost their eyelashes to chemotherapy or other illness, it still begs the question did the FDA act too soon to give the green light to this drug?  Is the potential for grave misuse, overuse, or other harmful long term side effects given the sensitive location of application of Latisse?  We only have 2 eyes.

The FDA does not have the best track record these days. (Some would argue it has never had a good track record.)  According to the New York Times,

“[weeks] after its own advisory board accused the Food and Drug Administration of failing to adequately consider research about the dangers of bisphenol-A, found in many plastic baby bottles, plastic food containers and metal can linings, the agency has agreed to reconsider the issue”

The article further states that the Center for Disease Control and Prevention has found that 93% of the urine from a sampled population contained BPA.  Finally, after an uproar, the FDA has decided to relook at this controversy. So, call me a skeptic when the FDA gives a drug their blessing.  I guess eye lash enhancements are more important than babies.

Other sources:

Nina Bai, “FDA Approves Drug That Promises Movie Star Eyelashes,” Blogs/80 Beats, Discover Magazine.com, December 30, 2008.

Toni Clark, “FDA approves Allergan’s drug for longer eyelashes,” Reuter, December 26, 2008.

Miranda Hitti, “FDA Oks 1st Eyelash Drug Latisse,” Skin and Beauty, WebMD Health News, December 26, 2008.

Jordan Lite, “Latisse: New Eyelash-Lengthening Drug Approved,” Scientific American, December 29, 2008.

Similar Posts:

  • Watermelon May be the New Natural Viagra
  • Safe Cleaning Products Ditch the Toxic Stuff. +DIY Recipes
  • Even your Inhaler is Going Green
  • Do You Know What Lurks in your Make-up Drawer?
  • Winter Gardening Prompts A Sci Fi Movie of Our Future Scary World

Grow From Seed Mini Course

Grow From Seed Mini Course

About Anna

Anna Hackman is the editor of Green Talk, and owner of The Naked Botanical and a avid (okay obsessed) gardener. She also loves video and podcasting and hosts Green Talk TV and Green Talk Radio. Her most important role is being a mother of four boys.

Chat with her on Facebook, Twitter, Pinterest , and Google+.

Comments

  1. 2

    Denise says

    January 27, 2009 at 7:19 pm

    Great article! Thank you for putting it together. Potential patients will be better served going with a service like The Patients Advantage (www.ThePatientsAdvantage.com). It’s a great way to find the best surgeons and it does not cost anything. I found them when searching for Botox providers. Check them out.

    Reply
  2. 3

    sharon says

    February 3, 2009 at 11:02 pm

    i was getting botox today and my dr told me about it, she us getting it next week… i can not wait to use it I have always had very short and thin eyelashes.. i cant wait for my new look . she charges 110 for the supply of 30 days… i will post a link on my process with photos on myspace….

    Reply
    • 4

      Green Talk says

      February 3, 2009 at 11:35 pm

      Sharon, thanks for letting us know that you are trying this procedure. I would love a my space link as to your progress and feeling about the product! Anna

      Reply
  3. 5

    CLAUDIA says

    March 15, 2009 at 1:51 pm

    HELLO I NEED TO BUY LATISSE . WHERE I CAN GETTING?

    CLAUDIA

    Reply
    • 6

      Green Talk says

      March 15, 2009 at 2:07 pm

      Claudia, you probably need to obtain this through a doctor such as a Dermatologist. Why do you need Latisse? Anna

      Reply
  4. 7

    joy says

    February 6, 2012 at 7:43 am

    I have also used the generic latisse for eye lash lengthening. It is really wonderful. It works wonders. $10 discount can also be got with the purchase of this drug online at International Drug Mart, by using the coupon code “15C2G”

    Reply
    • 8

      Anna@Green Talk says

      February 6, 2012 at 1:51 pm

      Joy, aren’t your afraid of it possibly changing your eye color? Anna

      Reply

Trackbacks

  1. Health Blog » Blog Archive » FDA Approves Latisse, Eyelash Enhancer, Yet No Ban on BPA. says:
    January 3, 2009 at 3:33 pm

    […] Read the original post: FDA Approves Latisse, Eyelash Enhancer, Yet No Ban on BPA. […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Shop from Anna’s Farm– The Naked Botanical– Farm Fresh Teas, Salts & Body Products

The Naked Botanical " Click HERE

Save Money By Growing Your Plants Indoors.

Three Must Have Equipment "

Grab My Free Mini Course

Connect with Me

  • Facebook
  • Google+
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Popular Posts

  • Organic Color Systems: Wash those Grays Away with a Safer Hair Color
  • Coffee Grounds in the Garden: Friend or Foe?
  • Celery Leaves: Cook or Discard them?

RSS Green Talk Radio

  • An error has occurred, which probably means the feed is down. Try again later.

Popular Posts

  • Organic Color Systems: Wash those Grays Away with a Safer Hair Color
  • Coffee Grounds in the Garden: Friend or Foe?
  • Celery Leaves: Cook or Discard them?
  • Freeze Cucumbers & Learn How to Use Them.
  • Hydrogen Peroxide + Ears = Bye to Colds. A Remedy that Works

RSS Green Talk TV

  • Turmeric indoor sowing time!
  • Short snippet of creating a rose hydrosol
  • Elderberry, more uses than just for health
  • The Naked Botanical's Gift Boxes
  • The Naked Botanical salts

Copyright Green Talk © 2022 · Website Designed by Clever Kiwi